Then, in February 2025, FDA removed semaglutide from its shortage list, giving some pharmacies, called 503A pharmacies, until April 22, 2025, to stop dispensing exact copies of semaglutide, and others, so-called 503B pharmacies, until May 22, 2025
If your insurance covers either medication, these programs may reduce your copay further
September 10, 2024: Woman Prescribed Ozempic Files Lawsuit for Failure to Warn In a story first reported by CBS News, Juanita Gantt shared that her doctor recommended she try Ozempic and Wegovy due to her heightened risk of diabetes and ongoing challenges with weight loss
Olsen, C
In the first undertaking toward that goal, GLP-1 was explored as an ideal pharmacological partner, leading to the purposeful discovery of the first GLP-1R/GcgR co-agonists